PLUS THERAPEUTICS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Austin, TX
SEC filing record 1 source field available
Fiscal year end
31 December
PLUS THERAPEUTICS, INC. has filed 1,451 SEC EDGAR filings since 30 Mar 2001

SEC filing history

Showing 76-100 of 281 matching filings.

Per page
25
Current page
4
8-K File 001-34375

Q2 2021 PR

Filing date
22 Jul 2021
Reporting date
22 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K

Filing date
20 May 2021
Reporting date
17 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

Q1 2021 PR

Filing date
22 Apr 2021
Reporting date
22 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K

Filing date
23 Feb 2021
Reporting date
23 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K

Filing date
22 Feb 2021
Reporting date
22 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K

Filing date
12 Jan 2021
Reporting date
08 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K

Filing date
23 Oct 2020
Reporting date
23 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K

Filing date
22 Oct 2020
Reporting date
22 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

2020 LPC

Filing date
06 Oct 2020
Reporting date
30 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K UNDERWRITER WARRANT AMENDMENT

Filing date
05 Oct 2020
Reporting date
29 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K FAST TRACK

Filing date
15 Sep 2020
Reporting date
15 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K

Filing date
10 Aug 2020
Reporting date
10 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K WARRANT AMENDMENT AUGUST 2020

Filing date
04 Aug 2020
Reporting date
30 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K

Filing date
17 Jun 2020
Reporting date
16 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K

Filing date
11 Jun 2020
Reporting date
08 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K

Filing date
14 May 2020
Reporting date
14 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K NANOTX

Filing date
11 May 2020
Reporting date
11 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K WARRANT AMENDMENT

Filing date
23 Apr 2020
Reporting date
17 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K Q4 19 EARNINGS RELEASE

Filing date
30 Mar 2020
Reporting date
30 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

NANOTX OXFORD

Filing date
30 Mar 2020
Reporting date
29 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K DIRECTORS AND EMPLOYMENT AGREEMENTS

Filing date
12 Mar 2020
Reporting date
09 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .